Contrasting Health In Tech (NASDAQ:HIT) and Firefly Neuroscience (NASDAQ:AIFF)

Health In Tech (NASDAQ:HIT) and Firefly Neuroscience (NASDAQ:AIFF) are both small-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, profitability, earnings and valuation.

Profitability

This table compares Health In Tech and Firefly Neuroscience’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Health In Tech	N/A	N/A	N/A
Firefly Neuroscience	-506.23%	-90.17%	-72.05%

Analyst Ratings

This is a breakdown of recent recommendations for Health In Tech and Firefly Neuroscience, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Health In Tech	1	0	1	1	2.67
Firefly Neuroscience	1	0	0	0	1.00

Health In Tech currently has a consensus price target of $3.50, suggesting a potential upside of 421.77%. Given Health In Tech’s stronger consensus rating and higher possible upside, equities research analysts plainly believe Health In Tech is more favorable than Firefly Neuroscience.

Institutional and Insider Ownership

5.0% of Firefly Neuroscience shares are held by institutional investors. 77.7% of Health In Tech shares are held by company insiders. Comparatively, 6.9% of Firefly Neuroscience shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Valuation & Earnings

This table compares Health In Tech and Firefly Neuroscience”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Health In Tech	$32.83 million	1.34	-$4.59 million	($0.07)	-9.58
Firefly Neuroscience	$1.14 million	14.73	-$19.88 million	($0.59)	-1.81

Health In Tech has higher revenue and earnings than Firefly Neuroscience. Health In Tech is trading at a lower price-to-earnings ratio than Firefly Neuroscience, indicating that it is currently the more affordable of the two stocks.

Risk and Volatility

Health In Tech has a beta of 2.81, indicating that its stock price is 181% more volatile than the S&P 500. Comparatively, Firefly Neuroscience has a beta of 0.51, indicating that its stock price is 49% less volatile than the S&P 500.

Summary

Health In Tech beats Firefly Neuroscience on 12 of the 15 factors compared between the two stocks.

About Health In Tech

Health in Tech, Inc. engages in the provision of insurance technology platforms which offer a marketplace of processes in the healthcare industry. Its services include Stone Mountain Risk, eDIYBS, HI Card, HI Performance Network, and Ancillary Products. The company was founded by Tim Johnson in 2014 and is headquartered in Stuart, FL.

About Firefly Neuroscience

Firefly Neuroscience, Inc., a medical technology and artificial intelligence company, provides neuroscientific solutions that improve outcomes for patients with mental illnesses and neurological disorders. The company offers Brain Network Analytics, a software that focuses on diagnostic and treatment for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. It serves pharmaceutical companies and medical practitioners. Firefly Neuroscience, Inc. is based in Toronto, Canada.